Xeris Pharmaceuticals Inc Stock Prediction and Forecast [XERS]

AI-generated source summary

The analysis of XERS stock, conducted on September 18, 2025, indicates it as a strong buy candidate. Since July 3, 2025, the stock has gained 74.74%, with an average daily gain of 1.38%. The short-term trend is upward, and the system predicts an 86.26% change in three months, targeting a range between $66.50% and $101.93%. A 12-month projection suggests a 113.73% increase, potentially reaching $12.43-$16.97. The last trading day saw an 8.21% increase, with a fluctuation of 7.91%. Support and resistance levels, combined with limited daily volatility, suggest a stop-loss at $7.98, minimizing risk.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   19 Sept 2025, 03:24 UTC

   The analyst published the original source item.

2. First prediction resolved

   15 Oct 2025, 15:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   15 Oct 2025, 15:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:15 UTC

   Tahlil Plus began monitoring the extracted predictions.